Kelly Narine
Technik-/Wissenschafts-/F&E-Leiter bei CARDIOL THERAPEUTICS INC.
Profil
Kelly Narine is currently the Director of Medical Affairs at Cardiol Therapeutics, Inc. and an Independent Director at Neural Therapeutics, Inc. Previously, she worked as the Director of Clinical Affairs at Afexa Life Sciences, Inc. and as the Vice President of Research at Aurora Cannabis, Inc. She received her doctorate degree from the University of Alberta in 2008.
Aktive Positionen von Kelly Narine
| Unternehmen | Position | Beginn |
|---|---|---|
| CARDIOL THERAPEUTICS INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2020 |
Neural Therapeutics, Inc.
 Neural Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. It has established a supply chain in Peru to source certain specimen of mescaline-containing cacti, such as the San Pedro cactus. The company is headquartered in Toronto, Canada. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Kelly Narine
| Unternehmen | Position | Ende |
|---|---|---|
Afexa Life Sciences, Inc.
 Afexa Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Afexa Life Sciences, Inc. engages in the development and commercialization of natural-based health products for disease prevention and health maintenance. Its product known as ChemBioPrint is used in the discovery and biological standardization of natural products that deliver consistent, verifiable and provable health benefits. The company was founded by Jacqueline Jie Shan on June 30, 1998 and is headquartered in Edmonton, Canada. | Technik-/Wissenschafts-/F&E-Leiter | - |
| AURORA CANNABIS INC. | Corporate Officer/Principal | - |
Ausbildung von Kelly Narine
| University of Alberta | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| AURORA CANNABIS INC. | Process Industries |
| CARDIOL THERAPEUTICS INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Neural Therapeutics, Inc.
Neural Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Neural Therapeutics, Inc. is an ethnobotanical drug-discovery company, which engages in the research and development of dietary supplements and psychedelic-based therapeutic medicines to treat mental ailments. It has established a supply chain in Peru to source certain specimen of mescaline-containing cacti, such as the San Pedro cactus. The company is headquartered in Toronto, Canada. | Health Technology |
Afexa Life Sciences, Inc.
Afexa Life Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Afexa Life Sciences, Inc. engages in the development and commercialization of natural-based health products for disease prevention and health maintenance. Its product known as ChemBioPrint is used in the discovery and biological standardization of natural products that deliver consistent, verifiable and provable health benefits. The company was founded by Jacqueline Jie Shan on June 30, 1998 and is headquartered in Edmonton, Canada. | Commercial Services |
